Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Avastin for Serosanguinous Maculopathy
NCT00344617Phase 3Unknown
- Sponsor
- Singapore National Eye Centre
- Start
- Jun 2006
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of bevacizumab in choroidal neovascularization (CNV), polypoidal choroidal vasculopathy (PCV), sponsored by Singapore National Eye Centre. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
choroidal neovascularization (CNV)polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT00344617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00344617.